ALZN: Alzamend Neuro, Inc. Kapitalizatsiya va daromad nisbati
Alzamend Neuro, Inc. (ALZN) salohiyati demensiya terapiyasi uchun sug'urta jamg'armalari to'lovlariga asoslangan. Innovatsion hujayraviy vaksinalar va litiy ishlanmalari firmaning ilmiy maqomini tasdiqlaydi, garchi spekulyativ loyihalar portfeli allaqachon narxga kiritilgan bo'lsa-da. GURU.Markets terminali kompaniyaning P/S grafigini namoyish etadi, bunda P/S narx harakati biznes qiymatini daromadga nisbatan aks ettiradi va joriy daraja hisoblanadi.
Alzamend Neuro, Inc. (ALZN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Alzamend Neuro, Inc.|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati alzamend.com|ALZN - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Alzamend|ALZN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Alzamend Neuro|Oraliq qoplash koeffitsiyenti alzamend.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ALZN - Sof foyda|Kompaniya foydasi prognozi Alzamend Neuro, Inc.|ALZN - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati alzamend.com|ALZN - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Alzamend|ALZN - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Alzamend Neuro|ALZN - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi alzamend.com|ALZN - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Alzamend Neuro, Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:Alzamend Neuro Inc., ALZN
Institutsional kapital Alzamend Neuro, Inc. (ALZN) kompaniyasining qiymatini ehtiyotkorlik bilan baholamoqda, chunki chakana savdo investorlarining Altsgeymer kasalligiga qarshi kurashga bo'lgan yuqori hissiy bog'liqligi ko'pincha aksiyalar narxini haqiqiy daromadlar nisbatida sun'iy ravishda oshiradi. P/S koeffitsiyenti dinamikasini tahlil qilish orqali investor bozor kapitalizatsiyasi va yillik tushumlar o'rtasidagi bog'liqlikni kuzatishi mumkin, bu esa klinik sinovlarning kelgusidagi muvaffaqiyati uchun to'langan premiumni aniqlashga va aktivning fundamental barqarorligini baholashga yordam beradi.
Alzamend Neuro, Inc. raqobatchilari
biogen.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori NBIX (Neurocrine Biosciences, Inc.)|RGC: Kapitalizatsiya va daromad nisbati|AXSM: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati VKTX|SUPN (Supernus) - P/S multiplikatori|Sotuvga nisbatan narx Catalyst Pharma CPRX|Kapitalizatsiyaning daromadga nisbati DNLI (Denali Therapeutics Inc)|P/S multiplikatori Harmony Corp (HRMY)|Narxning daromadga nisbati Biohaven Ltd. BHVN|Bozor kapitallashuvining daromadga nisbati AMLX|TRVI - Narxning daromadga nisbati|Sotuvga nisbatan narx Praxis Precision Medicines Inc|AVXL (Anavex Corp) - Kapitalizatsiyaning daromadga nisbati|CeriBell EEG - Bozor kapitallashuvining daromadga nisbati|PRTA (Prothena Biosciences) - P/S multiplikatori|Alector Therapeutics (ALEC) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Annexon (ANNX)|omeros.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori NGNE (Neurogene Corp)|ACIU - Kapitalizatsiyaning daromadga nisbati|VYGR: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti neumoratx.com NMRA|SCLX: P/S multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - P/S multiplikatori|Narxning daromadga nisbati Alpha Cognition Inc|Narxning daromadga nisbati CGTX|Kapitalizatsiyaning daromadga nisbati IKT (Inhibikase Therapeutics)|SAVA: Narxning sotuvga nisbati|Narxning daromadga nisbati Assertio ASRT|COYA: Kapitalizatsiya va daromad nisbati|VTGN - Narxning daromadga nisbati|OVID (Ovid Therapeutics Inc.) - Kapitalizatsiya va daromad nisbati|ABOS: P/S multiplikatori|Sotuvga nisbatan narx cervomed.com (CRVO)|Kapitalizatsiyaning daromadga nisbati ATHE|P/S multiplikatori Clene Nanomedicine|Narxning daromadga nisbati PepGen Inc. (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Relmada Therapeutics RLMD|annovisbio.com (ANVS) - Sotuvga nisbatan narx|Grace Tx - P/S multiplikatori|AIFF - P/S multiplikatori|anewmeds.com (KLTO) - Narxning daromadga nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati RVPH|MetaVia, Inc. - Narxning sotuvga nisbati|P/S multiplikatori NRXS|P/S multiplikatori heliusmedical.com (HSDT)|Narxning daromadga nisbati Passage Bio PASG|NEUP - Kapitalizatsiyaning daromadga nisbati|Minerva Neurosciences - P/S multiplikatori|Sotuvga nisbatan narx athira.com|Addex Therapeutics Ltd (ADXN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CYCN|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati KTTA (Pasithea)|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent, Inc.)|ATXI (avenuetx.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati BrainStorm Cell Therapeutics BCLI|CARA: Kapitalizatsiya va daromad nisbati|Chromocell Therapeutics Corporation - P/S multiplikatori|Sotuvga nisbatan narx Eliem Therapeutics|ITCI (intracellulartherapies.com) - Kapitalizatsiyaning daromadga nisbati|longboardpharma.com (LBPH) - P/S multiplikatori|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE - Sotuvga nisbatan narx|Synaptogenix, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati TRVN|Vigil Neuro - P/S multiplikatori|Narx/daromad koeffitsiyenti anewmeds.com WENA|Cerevel (CERE) - Narxning daromadga nisbati
